Czarnecka AM - Search Results

1

Involvement of the CB₂ cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212-2 in renal cell carcinoma.

Khan MI, Sobocińska AA, Brodaczewska KK, Zielniok K, Gajewska M, Kieda C, Czarnecka AM, Szczylik C. Khan MI, et al. Among authors: czarnecka am. BMC Cancer. 2018 May 23;18(1):583. doi: 10.1186/s12885-018-4496-1. BMC Cancer. 2018. PMID: 29792186 Free PMC article.

2

Ovarian cancer as a genetic disease.

Lech A, Daneva T, Pashova S, Gagov H, Crayton R, Kukwa W, Czarnecka AM, Szczylik C. Lech A, et al. Among authors: czarnecka am. Front Biosci (Landmark Ed). 2013 Jan 1;18(2):543-63. doi: 10.2741/4119. Front Biosci (Landmark Ed). 2013. PMID: 23276941 Free article. Review.

3

Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: from the patient's bed to molecular mechanisms.

Buczek M, Escudier B, Bartnik E, Szczylik C, Czarnecka A. Buczek M, et al. Biochim Biophys Acta. 2014 Jan;1845(1):31-41. doi: 10.1016/j.bbcan.2013.10.001. Epub 2013 Oct 14. Biochim Biophys Acta. 2014. PMID: 24135488 Review.

4

Vitamin D receptor gene polymorphisms in breast and renal cancer: current state and future approaches (review).

Khan MI, Bielecka ZF, Najm MZ, Bartnik E, Czarnecki JS, Czarnecka AM, Szczylik C. Khan MI, et al. Among authors: czarnecka am. Int J Oncol. 2014 Feb;44(2):349-63. doi: 10.3892/ijo.2013.2204. Epub 2013 Dec 2. Int J Oncol. 2014. PMID: 24297042 Free PMC article. Review.

5

Frontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinoma.

Czarnecka AM, Kornakiewicz A, Kukwa W, Szczylik C. Czarnecka AM, et al. Future Oncol. 2014 May;10(6):1095-111. doi: 10.2217/fon.13.258. Future Oncol. 2014. PMID: 24941992 Review.

6

Development of chronic myeloid leukaemia in patients treated with anti-VEGF therapies for clear cell renal cell cancer.

Czarnecka AM, Oborska S, Rzepecki P, Szczylik C. Czarnecka AM, et al. Future Oncol. 2015;11(1):17-26. doi: 10.2217/fon.14.135. Future Oncol. 2015. PMID: 24953672

7

The use of sunitinib in renal cell carcinoma: where are we now?

Czarnecka AM, Szczylik C, Rini B. Czarnecka AM, et al. Expert Rev Anticancer Ther. 2014 Sep;14(9):983-99. doi: 10.1586/14737140.2014.941815. Epub 2014 Jul 28. Expert Rev Anticancer Ther. 2014. PMID: 25066545

8

Tracheal adenoid cystic carcinoma mimicking a thyroid tumor: A case report.

Kukwa W, Korzeń P, Wojtowicz P, Sobczyk G, Kiprian D, Kawecki A, Kukwa A, Krzeski A, Szczylik C, Czarnecka AM. Kukwa W, et al. Among authors: czarnecka am. Oncol Lett. 2014 Sep;8(3):1312-1316. doi: 10.3892/ol.2014.2282. Epub 2014 Jun 25. Oncol Lett. 2014. PMID: 25120714 Free PMC article.

9

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma.

Bielecka ZF, Czarnecka AM, Szczylik C. Bielecka ZF, et al. Among authors: czarnecka am. Front Oncol. 2014 Jul 25;4:194. doi: 10.3389/fonc.2014.00194. eCollection 2014. Front Oncol. 2014. PMID: 25120953 Free PMC article. Review.

10

Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma.

Kornakiewicz A, Solarek W, Bielecka ZF, Lian F, Szczylik C, Czarnecka AM. Kornakiewicz A, et al. Among authors: czarnecka am. Curr Signal Transduct Ther. 2014 Dec;8(3):210-218. doi: 10.2174/1574362409666140206222746. Curr Signal Transduct Ther. 2014. PMID: 25152703 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters